Pascal's Memo: What's Next

[Anonymous]

Pascal's memo an interesting read. Is this the first shot a la Swan's video message about having to trim the fat. SS's program was to run through 2012.

 

[Anonymous]

please post it

 

[Anonymous]

please post it

If you didn't get the email, it's none of your business.

 

[Anonymous]

All I know is that the restructuring will contnue. Just left a meeting in SSF, we are charged with reshaping things again. No worries you will have 6-8 months

 

[Anonymous]

For all sales groups?

 

[Anonymous]

The world is ending. The world is ending. The world is ending. Say it with me...

 

[Anonymous]

It is vague but also very clear. The cutting has only just begun. Now is the time to make your exit plan.

 

[Anonymous]

It is vague but also very clear. The cutting has only just begun. Now is the time to make your exit plan.

Thanks for the advice. Several Oncology expansions coming up, new start ups, then Seattle Genetics offered a spot and I wasn't sure if it was worth the risk. Pascale's email came and the scales of risk tilted , now sounds like it's even. Hmmmm. Maybe if enough go elsewhere others will be safe. Thoughts?

 

[Anonymous]

Nowhere is the pharma, and yes even if you sell oncology you are part of pharma, is safe. It's a dying industry for sales people.

Gone are the glory days of huge sales forces with drugs that sell themselves (thats pointed at you oncology reps) and only matter what formulary you are on.

Genentech, as well as other companies, will continue to develop into marketing companies and eventually lay off the entire sales force. Why would you need a sales force when what matters most is formulary status.

I will now wait for replies.